Sign In
Buy SAVA
$1.96
+0 (+0%)
At Close: Jun 03, 2026
Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock?
01:42pm, Friday, 31'st Dec 2021 Zacks Investment Research
Investors need to pay close attention to Cassava Sciences (SAVA) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in Cassava Sciences (SAVA) Stock?
09:58am, Friday, 31'st Dec 2021
Investors need to pay close attention to Cassava Sciences (SAVA) stock based on the movements in the options market lately.
Cassava Sciences, Inc. - A Rational Expectation If All Goes Well With Simufilam
09:01am, Thursday, 30'th Dec 2021
I do not believe that a short position in Cassava Sciences stock is rational.
7 of the Best Meme Stocks for 2022 to Buy Now
06:00am, Thursday, 30'th Dec 2021
Although the meme stocks phenomenon is sagging in popularity, these seven current and/or former Reddit favorites could make another "to the moon" move or two in 2022. The post 7 of the Best Meme Stock
5 Stocks I'd Sell Right Now
10:51am, Wednesday, 29'th Dec 2021 The Motley Fool
These could be some of the worst-performing and riskiest investments in 2022.
5 Stocks I'd Sell Right Now
05:51am, Wednesday, 29'th Dec 2021
These could be some of the worst-performing and riskiest investments in 2022.
Best Health Care Stocks To Buy Now? 3 For Your 2022 Watchlist
02:59pm, Tuesday, 28'th Dec 2021
Health care stocks worth knowing as the Omicron Covid-19 variant sweeps the globe.
Cassava Sciences Launches Clinical Website to Support Phase 3 Studies of Oral Simufilam in Alzheimer’s Disease
02:00pm, Thursday, 23'rd Dec 2021 GlobeNewswire Inc.
AUSTIN, Texas, Dec. 23, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc., (NASDAQ: SAVA) a biotechnology company, today announced the launch of a new clinical website, called www.Rethink-ALZ.com. Ret
Science Journal Finds No Evidence To Data Manipulation By Cassava Sciences'' In 2005 Publication
08:01pm, Tuesday, 21'st Dec 2021 Business Insider Markets
Cassava Sciences Inc (NASDAQ: SAVA ) has been informed by the Neuroscience journal that there is no evidence to support claims of data…
SAVA Stock Alert: What Is Going on With Red-Hot Cassava Sciences Today?
05:40pm, Tuesday, 21'st Dec 2021
Biotech company Cassava saw a big jump today on positive news related to its Alzheimer's disease treatment. Keep an eye on SAVA stock.
Biogen (BIIB) to Cut Alzheimer's Drug Aduhelm Price by 50%
05:16pm, Tuesday, 21'st Dec 2021 Zacks Investment Research
Biogen (BIIB) said it is lowering the wholesale acquisition cost (WAC) of Aduhelm by approximately 50%, effective Jan 1, 2022
Top Penny Stocks To Buy? 3 Former Stocks Under $5 To Watch Now
03:44pm, Tuesday, 21'st Dec 2021 PennyStocks
Are these former penny stocks on your list to buy right now or is the rally over?
The post Top Penny Stocks To Buy? 3 Former Stocks Under $5 To Watch Now appeared first on Penny Stocks to Buy, Picks,
Cassava Sciences Stock: Here We Go Again
03:40pm, Tuesday, 21'st Dec 2021
While the interim data looks fantastic, and some are pushing for early approval of the drug by the FDA, some questions remain surrounding the academic integrity of the work.
Science Journal Finds No Evidence To Data Manipulation By Cassava Sciences' In 2005 Publication
03:01pm, Tuesday, 21'st Dec 2021
Cassava Sciences Inc (NASDAQ: SAVA) has been informed by the Neuroscience journal that there is no evidence to support claims of data manipulation in a 2005 paper authored by the Company and its scie
Science Journal Finds No Evidence to Support Claims of Data Manipulation in 2005 Publication
02:30pm, Tuesday, 21'st Dec 2021 GlobeNewswire Inc.
AUSTIN, Texas, Dec. 21, 2021 (GLOBE NEWSWIRE) -- Cassava Sciences, Inc., (Nasdaq: SAVA) a biotechnology company, has been informed by Neuroscience journal there is no evidence to support claims of d
